• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance

cafead

Administrator
Staff member
  • cafead   May 09, 2023 at 10:52: AM
via Contract manufacturer Catalent announced Monday it is pushing back its third fiscal quarter earnings report and investor call originally set for Tuesday. The company now expects to release its financial results on May 15.

article source